The Water-Blueberry Study

Sponsor
University of Oslo (Other)
Overall Status
Completed
CT.gov ID
NCT00520871
Collaborator
Ullevaal University Hospital (Other)
62
13

Study Details

Study Description

Brief Summary

We will study the effect of supplementation of 1 L blueberry juice to participants with at least one elevated cardiovasculat risk factor.

Condition or Disease Intervention/Treatment Phase
  • Drug: Blueberry juice
Phase 1/Phase 2

Detailed Description

Participants with at leat one elevated cardiovacsular risk factor, as defined as systolic blood pressure between 140 and 165 mmHg, diastolic blood pressure between 90 and 105 mmHg, low density lipoprotein (LDL) cholesterol ≥3.4 mmol/L, total/high density lipoprotein (HDL) cholesterol ratio >4 or smoking a minimum of 3 cigarettes daily.

Subjects were randomized to two groups, where the blueberry group were supplemented with 1 L blueberry juice per day for four weeks. The control group consumed an equal amount of water.

Clinical markers, as well as biomarkers of antioxidant status, oxidative stress status and inflammation were measured in blood samples before amd after the intervention period.

Study Design

Study Type:
Interventional
Actual Enrollment :
62 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single
Primary Purpose:
Prevention
Official Title:
The Effect of Blueberry Juice on Cardiovascular Risk Factors, and Markers of Antioxidant Status, Oxidative Stress Status and Inflammation.
Study Start Date :
Mar 1, 2003
Actual Study Completion Date :
Apr 1, 2004

Outcome Measures

Primary Outcome Measures

  1. Primary endpoints are cardiovascular risk factors [4 weeks]

Secondary Outcome Measures

  1. Secondary endpoints are additional clinical markers, as well as biomarkers of antioxidant status, oxidative stress status and inflammation [4 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 30-70 years for men and 45-70 years or at least 12 months postmenopausal for women

  • at least one elevated cardiovascular risk factor, defined as systolic blood pressure between 140 and 165 mmHg, diastolic blood pressure between 90 and 105 mmHg, low density lipoprotein (LDL) cholesterol ≥3.4 mmol/L, total/high density lipoprotein (HDL) cholesterol ratio >4 or smoking a minimum of 3 cigarettes daily.

Exclusion Criteria:
  • clinically recognized chronic diseases as impaired renal function, diabetes mellitus, cardiovascular disease, liver or gastrointestinal disease or cancer within the last 5 years

  • use of lipid-lowering drugs, diuretics or hormone replacement therapy for women

  • Subjects with a body-mass index ≥31

  • with a alcohol consumption above 3 units/day for men and 1 unit/day for women

  • blood donation within the last six months

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Oslo
  • Ullevaal University Hospital

Investigators

  • Principal Investigator: Rune Blomhoff, PhD, University of Oslo
  • Principal Investigator: Serena Tonstad, MD, Ullevaal University Hospital
  • Principal Investigator: Anette Karlsen, MSc, University of Oslo

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00520871
Other Study ID Numbers:
  • Water-Blueberry Study
  • REK SØR ref nr 39-03-01166
First Posted:
Aug 27, 2007
Last Update Posted:
Aug 27, 2007
Last Verified:
Aug 1, 2007
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 27, 2007